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Super-absorbent dressings:
how do they perform in vitro?
Abstract
The free swell and absorption capacity under compression of six 
wound dressings that are indicated for moderately to highly exuding 
wounds was investigated. Measuring in vitro the absorptive capacity 
and retention under compression is important in terms of clinical 
efficacy and efficiency. This in vitro comparative study demonstrated 
that sorbion sachet EXTRA had the highest free swell capacity of the 
six test dressings and absorbed more than twice the volume (126%) of 
the test solution than its nearest competitor. When measuring capacity 
under compression, sorbion sachet EXTRA absorbed 88% more fluid 
than the nearest competitor.
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Wounds, particularly chronic wounds can have a significant impact on patient quality of life (Cutting, 2010) and their management requires prudent use of the resources that 
are most appropriate in the given clinical circumstances. 
Dressings are applied to wounds for a variety of reasons 
including protection, prevention of blood loss and other 
fluids, to provide the optimal environment for healing, 
for aesthetic reasons, and for the absorption of wound 
exudate. Clinician requirements in terms of wound dressing 
performance are becoming more complex but there remains 
a need for sustained efficiency in terms of the management 
of exudate. Wound healing is a dynamic process and 
although wound exudation is a visual manifestation of the 
inflammatory response (Bishop et al, 2003), the volume 
of exudate produced together with its consistency and 
chemical composition can vary considerably between 
patients and over time. Measuring the fluid-handling 
capabilities of dressings is of importance when considering 
the absorptive capacity and the ability to retain the 
absorbed fluid under application of external pressure. These 
performance attributes have strong implications in terms of 
efficacy and associated patient outcomes.
In recent years, there has been a considerable increase 
in the number of dressings that are based on matrices 
comprising super absorbent polymers (SAPs). Such dressings 
have achieved escalating attention as they are designed to 
have increased absorption capacity (Tadej, 2009) and to bind 
or retain fluid by converting it into a gel, locking it away 
within the dressing. This action is to protect the wound and 
peri-wound skin from enduring contact with an excessively 
moist/wet dressing interface. Consequently, these dressings are 
designed to be most appropriate for application to moderate 
to highly exuding wounds. Poor exudate management 
increases patient morbidity and costs for the healthcare 
facility (White and Cutting, 2006). The increasing interest 
shown in the exudate-handling capabilities of modern 
Keith F Cutting and Samantha J Westgate
dressings may be seen in experimental work undertaken by 
McCall and colleagues investigating real-time monitoring 
of wound dressing moisture levels in vitro (McCall et al, 
2007). In additional in vitro tests, Thomas identified marked 
differences in product performance that he considered could 
be reflected in treatment cost (Thomas, 2010).
Dressings containing SAPs have been designed 
and constructed with a variety of polymers of varying 
specifications that may or may not be combined with other 
components that influence dressing performance. As the 
mere presence of SAPs does not guarantee optimal wound 
dressing performance, the fluid-handling characteristics of 
different technologies have been assessed. Clinicians should 
be conversant with the performance attributes of available 
dressings so that fully informed decisions on dressing choice 
can be made. 
Free swell and absorption under compression
Free swell is a ‘dunk-and-drip’ test that measures the uptake 
of fluid by a dressing following a period of immersion (dunk) 
in the test solution and then allowed to drain (drip). This test 
method provides a numerical value of dressing absorbent 
capacity and is most relevant clinically to those wounds that 
are not subjected to application of pressure from external 
sources such as abdominal surgical wounds or thigh graft 
donor sites. In these situations, the dressing is kept in place 
by a retention device, e.g. adhesive tape or a light conforming 
bandage. Often, wounds that produce large volumes of 
exudate such as venous leg ulcers require application of a 
bandage or hosiery that exerts an externally applied pressure 
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of approximately 40 mmHg at the ankle. The compression 
device retains the dressing in place and exerts a pressure, not 
only on the lower limb but also on the dressing, that has 
been applied to the ulcer at far greater levels than would 
be found with a simple conforming bandage or adhesive 
tape. Compression, therefore, influences the fluid-uptake 
characteristics of the wound dressing and compromises its 
absorbent capacity and retention capabilities. 
The objectives of this study were to:
 Q Compare the free swell (absorptive) capacity of six popular 
wound dressings used in the management of moderately to 
heavily exuding wounds
 Q Compare the absorbent capacity under compression of the 
same six wound dressings.
The in vitro tests reported here have employed recognised 
methods that are devised to measure free swell and absorption 
under compression of six wound dressings.  
In addition to existing data relating to dressings’ clinical 
performance and patient acceptance, it is the intention that 
the data reported here will provide a point of reference 
for clinicians and indeed medicine managers, and facilitate 
dressing choice.
Methods
Test dressings used were sorbion sachet EXTRA (sorbion 
GmbH & Co. KG), Curea P1 (Curea-Medical GmbH), 
Cutisorb Ultra (BSN Medical), DryMax EXTRA (Absorbest 
AB), Flivasorb (Lohmann & Rauscher), Kerramax (Crawford 
Healthcare).
Data in respect of free swell and absorbent capacity under 
compression were prepared by an independent testing 
laboratory; SAS Hagmann GmbH, Weberstrasse 3, D-72160 
Horb am Neckar, Germany.
A comparison between the unit cost of each dressing and 
the average cost of absorption per 100 ml absorbed will also 
be made.
Experiment 1
The free swell capacity of absorbent primary wound dressings 
followed the standard EN13726-1:2002 except where 
indicated below. The test dressings were weighed using a 
calibrated balance and then immersed in a tank containing 
a test solution of NaCl 0.83% with CaCl2 0.037% at 37oC 
where they remained for 30 minutes. Dressings were removed 
from the solution, transferred onto a grid and then into an 
empty receiving tray, where they were allowed to drain for 
30  seconds before being re-weighed. The volume of fluid 
used was equivalent to 40  times the weight of each dry 
dressing. In order to enhance the clinical relevance of this 
in vitro test, commercially available dressings measuring 
10 cm x 10 cm were tested in each case instead of 5 cm x 5 cm 
dressings as indicated in the EN standard. All dressings were 
tested in triplicate and the mean absorbency was calculated.
Experiment 2
The test dressings were weighed using a calibrated balance 
and then placed on a perforated metal tray. A weight of 
5.42 kg was then placed on the surface of the dressing so 
that a pressure equivalent to 40  mmHg could be evenly 
applied to the dressing surface. The tray and the dressing 
were then immersed in a test solution of NaCl 0.83% with 
CaCl2 0.037% for 30  minutes at room temperature. The 
dressings were removed from the test solution and then 
re-weighed. The absorbent capacity was then determined 
as the difference in weight between the wet dressing after 
30  minutes of uptake (with an additional 5  minutes of 
drainage) and the dry state. Dressings were tested in triplicate 
and the mean absorbency was calculated.
Statistics
Two-tailed t-test was used to compare the free swell 
absorption capacity of the dressings and also the absorption 
capacity under compression of the test dressings. Statistical 
tests were carried out using Microsoft Excel 2011 and 
p values of <0.05 were considered significant. 
Results
Experiment 1
The sorbion sachet EXTRA 10  cm x 10  cm dressing 
absorbed 224  ml of the test solution (Figure 1). This was 
the highest free swell capacity of the six test dressings and 
equated to 126% more of the test solution than its nearest 
competitor (p<0.001). 
There were also significant differences in free swell 
absorption between the other dressings as shown by the 
p values in Table 1. 
Flivasorb absorbed significantly more than Cutisorb 
Ultra (p=0.0014) and KerraMax (p< 0.0001). Cutisorb 
Figure 1. Mean free swell capacity of six unmodified 10 cm X 10 cm test dressings. Error bars indicate the standard deviations.
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Ultra absorbed significantly more than KerraMax 
(p < 0.0001). Curea P1 absorbed significantly more than 
KerraMax (p < 0.0001), Cutisorb Ultra (p=0.0003) and 
DryMax EXTRA (p=0.0059). DryMax EXTRA absorbed 
significantly more than Cutisorb Ultra (p=0.0001).
The mean cost per 100 ml absorbed of the test solution per 
dressing in ascending order may be seen in Table 2. 
Experiment 2
The absorption capacity of all the dressings was decreased 
compared with the free swell absorption (Figure 1 and 
Figure 2). The sorbion sachet EXTRA dressing absorbed 
107  ml/100  cm2 and was 88% more absorbent than the 
nearest competitor (p=0.0001). The absorption trends of 
the dressings were similar to those observed in the free swell 
study. 
Significant differences were found in absorption under 
compression between the other dressings as shown by the 
p values in Table 3.
Flivasorb absorbed significantly more than Curea P1 
(p=0.0023), DryMax EXTRA (p=0.0012), Cutisorb Ultra 
(p=0.0023) and KerraMax (p=0.0004). Curea P1 absorbed 
significantly more than DryMax EXTRA (p=0.0124), 
Figure 2. Mean absorbent capacity of six unmodified 10 cm X 10 cm test dressings under compression equivalent to 40 mmHg. Error bars indicate the 
standard deviations
Table 2. The actual cost of a single  
10 cm x 10 cm dressings (Drug Tariff, 
August 2012) and the mean cost  
per 100 ml fluid absorption.
Dressing
Price 
(£)
Mean cost 
per 100ml 
absorbed (£)
Standard 
deviation
sorbion sachet 
EXTRA
2.25 1.00 ±0.35
Kerramax 0.93 1.72 ±0.02
Drymax 
EXTRA
1.84 1.94 ±0.009
Curea P1 2.10 2.12 ±0.31
Flivasorb 2.20 2.27 ±0.04
Cutisorb Ultra 2.05 2.30 ±0.01
Table 1. Level of statistical significance in free swell absorbency between the six test 
dressings. ns = no significance
Cutisorb 
Ultra
Curea P1 Flivasorb DryMax Extra
sobion 
sachet Extra
KerraMax
Cutisorb Ultra
Curea P1 p=0.0003
Flivasorb p=0.0014 N/S
DryMax 
EXTRA
p=0.0001 p=0.0059 N/S
sobion sachet 
EXTRA
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001
KerraMax p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001
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and KerraMax (p=0.0008). DryMax EXTRA absorbed 
significantly more than KerraMax (p=0.0215).
The mean cost per 100 ml absorbed under compression 
of the test solution per dressing in ascending order may be 
seen in Table 4.  
Discussion
Inadequate management of wound exudate can have 
disastrous results for the patient and cause maceration of 
the peri-wound skin and consequential delays in healing. 
When healing is delayed, there is an increased risk of ensuing 
infection that will not only increase patient morbidity but 
also increase costs for the healthcare facility in terms of 
material resources and nursing time (Wolcott et al, 2010). 
This highlights the importance of diligence in wound 
dressing choice. 
The experiments reported here clearly emphasise that 
‘effectiveness’ in wound care products that share, or are 
said to share, one or more ingredients are likely to deliver 
widely varying results. Clinicians have a responsibility to 
identify and select clinical interventions that are expected 
to achieve optimal patient outcomes within the relevant 
clinical circumstances (Cutting and White, 2012). Therefore, 
in managing moderately to highly exuding wounds, patients 
require wound dressings that will not only absorb a large 
volume of fluid but will also retain that fluid when subjected 
to external pressures similar to those exerted by graduated 
external compression bandages. 
The level of performance (free swell) has implications not 
only in terms of patient management but also in costs to the 
care facility/provider. Table 2 and Table 4 do not take into 
account other potential cost implications when considering 
nursing time to change patient dressings that require more 
frequent attention as they have a lower absorptive capacity. 
There is a risk that the concept of unit cost may be used as 
a criterion for dressing selection and thereby discount use of 
those products perceived as ‘too expensive’ in the SAP category. 
Focusing on unit cost as the sole criterion for dressing choice 
is a misguided attempt at cost containment. When managing 
moderate to heavily exuding wounds, an alternative approach 
is to consider dressing performance in terms of fluid-handling 
costs of absorption/retention. Different dressings have specific 
design and material characteristics that inevitably lead to 
variations in performance. The sorbion sachet EXTRA 
dressing is the least expensive per 100 ml absorbed in both 
free swell and under simulated compression circumstances.
When managing patients with wounds that produce 
Table 3. Differences in the absorbency under compression reported between the six test 
dressings. ns= not significant
Cutisorb 
Ultra
Curea P1 Flivasorb
DryMax 
EXTRA
sobion 
sachet EXTRA
KerraMax
Cutisorb Ultra
Curea P1 N/S
Flivasorb p=0.0023 p=0.0023
DryMax 
EXTRA
N/S p=0.0124 p=0.0012
sobion sachet 
EXTRA
p < 0.0001 p < 0.0001 p=0.0001 p < 0.0001
KerraMax N/S p=0.0008 p=0.0004 p=0.0215 p < 0.0001
Table 4. The actual cost of a single  
10 cm x 10 cm dressings (Drug Tariff, 
August 2012) and the mean cost per 100 
ml absorbed under compression
Dressing
Price 
(£)
Mean cost per 
100ml fluid 
absorbed under 
compression (£)
Standard 
deviation
sorbion 
sachet 
EXTRA
2.25 2.10 ±0.08
Kerramax 0.93 3.00 ±0.22
Flivasorb 2.20 3.87 ±0.22
Curea P1 2.10 4.79 ±0.02
DryMax 
EXTRA
1.84 4.84 ±0.29
Cutisorb 
Ultra
2.05 6.27 ±0.91
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moderate-to-high levels of exudate, it is essential that dressing 
choice decisions are based on fundamental performance 
attributes. However, it is important to state that the application 
of in vitro test methodology should be viewed as no more 
than a guide and not be regarded as an alternative to human 
disease in vivo testing. It is acknowledged that, clinically, the 
consistency and rate of production of exudate varies from the 
described test methodology. In addition, the weight of the 
dressing increases as it absorbs exudate and this may be at a 
level inconsistent with patient comfort. This event should be 
regarded as a clinical indication that the dressing should be 
changed. Nonetheless, the use of in vitro tests in the selection 
of wound care products has provided guidance on the 
physical characteristics of dressings for a number of decades, 
e.g. vapour permeability (Erasmus and Jonkman, 1989), odour 
containment (Thomas et al, 1998) and absorbency (Thomas 
and Fram, 2001).
Scientific data of comparative wound dressing absorbency 
performance in terms of free swell and absorbency under 
compression assists in laying the foundations upon which 
clinical decisions can be made. This should lead us away from 
relying on unit cost of dressing as a discrete criterion for 
dressing selection and encourage the inclusion of clinician/
patient satisfaction data.
Conclusion
Advanced wound dressings are designed with specific 
function(s) in mind and this functionality will be determined 
by the dressing’s material properties. Although the polymer 
dressings reported here are claimed to be suitable for 
moderate to highly exuding wounds, clinicians need to bear 
in mind that unit cost of dressing and the associated costs 
related to nursing time and dressing change interval should 
be included in the decision-making process.
Variation in wound dressing performance is a consequence 
of the inherent design and material characteristics. Clinicians 
should carefully discriminate between products and base 
their choice on the desired performance outcomes/functions 
that are supported by sound evidence. These would include 
the absorbent capacity potential and the ability to retain the 
absorbed effluent within the dressing matrix where a moist 
(not wet) environment is maintained also under compression.
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KEY POINTS
 Unit cost of wound dressings should not be used as a sole criterion for 
dressing selection
 Clinicians should take into account the costs of dressing fluid-handling 
capabilities such as absorption and retention when selecting dressings
 Different dressings have specific design and material characteristics that lead 
to variations in performance
 Wound dressing absorptive capacity can be influenced 
by external compression
